Physician profile
Tami Watkins
NPI 1033622212
$3,314.77
in general payments reported to CMS, 2019-2025
18 companies · $33.93 in 2025
The $33.93 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $340 · 2022: $551 · 2023: $1,909 · 2024: $480 · 2025: $33.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,413 · Food and Beverage: $1,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,413.20 |
| Food and Beverage | $1,010.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thd America, INC. | $1,041.29 | 2023-2024 | |
| Axonics, INC. | $886.03 | 2023-2024 | Axonics |
| Medical Device Business Services, INC. | $468.13 | 2022 | |
| Abbvie INC. | $181.10 | 2023-2025 | |
| Ethicon US, LLC | $163.27 | 2021-2022 | |
| Celgene Corporation | $123.03 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $121.12 | 2021 | |
| Janssen Biotech, INC. | $65.63 | 2023-2024 | Stelara |
| Karl Storz Endoscopy-America | $46.42 | 2023 | Radiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.07 | 2024 | Xifaxan |
| Kerecis Limited | $30.35 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Depuy Synthes Sales INC. | $24.11 | 2024 | Healix Knotless Peek, Quickanchor Orthocord, Dynatape |
| Regeneron Healthcare Solutions, INC. | $24.01 | 2024 | Dupixent |
| Ipsen Biopharmaceuticals, INC | $22.48 | 2024 | Iqirvo |
| Aroa Biosurgery Incorporated | $20.85 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $18.55 | 2023 | Sutab |
| Smith+Nephew, INC. | $16.61 | 2024 | Pico 14 |
| Coloplast Corp | $15.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tami Watkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.